C
Corvus Pharmaceuticals, Inc. (CRVS)
NGM – Real vaqt narxi. Valyuta: USD
15.05
+0.32 (2.17%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
15.05
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:15 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
15.05
+0.32 (2.17%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
15.05
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:15 PM EDT
This stock has a consensus price target of $28.86 based on the ratings of 8 analysts. The high is $42.00 and the low is $11.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 11 | $ 28.86 | $ 42 |
| O’zgarish | -19.94% | 110.04% | 205.68% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-17 | 166.13% | Goldman Sachs | $40 | Initiates Coverage On | Buy |
| 2026-03-13 | 119.56% | Oppenheimer | $32 → $33 | Reiterates | Outperform |
| 2026-01-22 | 179.44% | Jefferies | $13 → $42 | Maintains | Buy |
| 2026-01-21 | 112.91% | Oppenheimer | $15 → $32 | Maintains | Outperform |
| 2026-01-21 | 86.29% | Barclays | $16 → $28 | Maintains | Overweight |